Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 392

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 392
---
ac
     
    10-K
     
    001-14895
     
    10.59
     
    3/1/21

     10.51†
     
    Offer Letter dated April 19, 2018 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klapac
     
    10-K
     
    001-14895
     
    10.60
     
    3/1/21

     10.52†
     
    Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Ian M. Estepan
     
    10-K
     
    001-14895
     
    10.61
     
    3/1/21

-89-

     10.53†
     
    Offer Letter dated by December 18, 2014 and between Sarepta Therapeutics, Inc. and Ian M. Estepan
     
    10-K
     
    001-14895
     
    10.62
     
    3/1/21

     10.54
     
    Amendment no. 1 dated October 23, 2020 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21, 2019
     
    10-Q
     
    001-14895
     
    10.1
     
    8/4/21

     10.55
     
    Amendment no. 14 dated October 31, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21, 2019
     
    10-K
     
    001-14895
     
    10.74
     
    2/28/24

     10.56^
     
    Amendment No. 2, dated November 17, 2021 to License Agreement between Sarepta Therapeutics, Inc. and ST International Holdings Two, Inc. on the one hand and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on